| Package | Version | Identity | Name/Title | Status | FMM | WG | Date | Realm | Auth | Source(s) |
|---|
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.1444.3.203.json | BRCA1 | active | | | 2023-06 | us | hl7 | loinc |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.1444.3.204.json | BRCA2 | active | | | 2023-06 | us | hl7 | loinc |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.1444.3.205.json | BRCA1 Testing | active | | | 2023-06 | us | hl7 | cpt |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.1444.3.207.json | Epithelial Ovarian Cancer | active | | | 2024-08 | us | hl7 | sct |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.1444.3.208.json | Primary Peritoneal Cancer | active | | | 2022-06 | us | hl7 | sct |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.1444.3.209.json | Fallopian Tube Cancer | active | | | 2022-06 | us | hl7 | sct |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.1444.3.210.json | Multigene Panel | active | | | 2023-07 | us | hl7 | cpt |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.1444.3.211.json | BRCA1 and BRCA2 | active | | | 2023-06 | us | hl7 | loinc |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.1444.3.212.json | BRCA1 and BRCA2 Testing | active | | | 2023-06 | us | hl7 | cpt |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.1444.3.213.json | BRAF V600 | active | | | 2022-01 | us | hl7 | loinc |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.1444.3.214.json | BRAF V600 Testing | active | | | 2023-04 | us | hl7 | cpt |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.1444.3.215.json | Colorectal Cancer | active | | | 2024-08 | us | hl7 | sct |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.1444.3.216.json | BRAF V600 Mutation Status | active | | | 2022-01 | us | hl7 | loinc |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.1444.3.217.json | Cancer Stage I | active | | | 2024-08 | us | hl7 | sct |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.1444.3.218.json | Head and Neck Cancer | active | | | 2022-02 | us | hl7 | icd |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.1444.3.219.json | Malignant Melanoma of Skin | active | | | 2022-06 | us | hl7 | icd |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.1444.3.220.json | Brain Cancer | active | | | 2022-07 | us | hl7 | icd |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.1444.3.221.json | Waldenstrom Macroglobulinemia | active | | | 2024-08 | us | hl7 | icd |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.1444.3.222.json | High Emetic Risk Intravenous Antineoplastic Agent | active | | | 2025-04 | us | hl7 | rx |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.1444.3.223.json | Moderate Emetic Risk Intravenous Antineoplastic Agent | active | | | 2025-04 | us | hl7 | rx |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.1444.3.224.json | Docetaxel Injectable | active | | | 2024-12 | us | hl7 | rx |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.1444.3.225.json | Cyclophosphamide Injectable | active | | | 2022-09 | us | hl7 | rx |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.1444.3.226.json | LAG 3 Inhibitor | active | | | 2024-11 | us | hl7 | rx |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.1444.3.233.json | Chemotherapy Administration | active | | | 2024-01 | us | hl7 | cms |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.1444.3.240.json | Pathological N Stage N3c | active | | | 2024-09 | us | hl7 | sct |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.1444.3.241.json | Audio Visual Telehealth Encounter | active | | | 2025-01 | us | hl7 | cpt |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.1444.3.242.json | Moderate or High Emetic Risk Oral Antineoplastic Agent | active | | | 2025-04 | us | hl7 | rx |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.1444.3.243.json | Minimal to Low Emetic Risk Oral Antineoplastic Agent | active | | | 2025-04 | us | hl7 | rx |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.1444.3.244.json | Copanlisib Injectable | active | | | 2025-04 | us | hl7 | rx |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.1444.3.245.json | Isatuximab Injectable | active | | | 2025-04 | us | hl7 | rx |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.1444.3.246.json | Loncastuximab tesirine Injectable | active | | | 2025-04 | us | hl7 | rx |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.1444.3.247.json | Margetuximab Injectable | active | | | 2025-04 | us | hl7 | rx |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.1444.3.248.json | Mirvetuximab soravtansine Injectable | active | | | 2025-04 | us | hl7 | rx |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.1444.3.249.json | Tafasitamab Injectable | active | | | 2025-04 | us | hl7 | rx |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.1444.3.250.json | Teclistamab Injectable | active | | | 2025-04 | us | hl7 | rx |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.1444.3.251.json | Tisotumab Injectable | active | | | 2025-04 | us | hl7 | rx |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.1444.3.252.json | Asparaginase Injectable | active | | | 2025-04 | us | hl7 | rx |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.1444.3.254.json | Belantamab Injectable | active | | | 2025-04 | us | hl7 | rx |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.1444.3.255.json | Dostarlimab Injectable | active | | | 2025-04 | us | hl7 | rx |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.1444.3.256.json | Mosunetuzumab Injectable | active | | | 2025-04 | us | hl7 | rx |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.1444.3.257.json | Tremelimumab Injectable | active | | | 2025-04 | us | hl7 | rx |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.1444.3.258.json | Indication for Dexamethasone | active | | | 2025-04 | us | hl7 | sct |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.1444.3.260.json | Indication for Olanzapine | active | | | 2025-04 | us | hl7 | sct |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.1444.3.261.json | Indication for Dexamethasone | active | | | 2025-04 | us | hl7 | icd |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.1444.3.263.json | Indication for Olanzapine | active | | | 2025-04 | us | hl7 | icd |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.1444.3.264.json | Prednisone | active | | | 2025-04 | us | hl7 | rx |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.1444.3.265.json | As Needed PRN | active | | | 2025-04 | us | hl7 | sct |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.1444.3.266.json | Amivantamab Injectable | active | | | 2025-04 | us | hl7 | rx |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.1444.5.200.json | Doxorubicin | active | | | 2020-09 | us | hl7 | vsac |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.1444.5.201.json | Epirubicin | active | | | 2020-09 | us | hl7 | vsac |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.1444.5.202.json | Capecitabine | active | | | 2023-06 | us | hl7 | vsac |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.1444.5.203.json | Cyclophosphamide | active | | | 2020-09 | us | hl7 | vsac |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.1444.5.204.json | Injectable Fluorouracil | active | | | 2020-09 | us | hl7 | vsac |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.1444.5.205.json | Methotrexate | active | | | 2020-09 | us | hl7 | vsac |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.1444.5.206.json | Trastuzumab and Biosimilars | active | | | 2020-09 | us | hl7 | vsac |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.1444.5.207.json | HER2 Presence in Tissue | active | | | 2022-03 | us | hl7 | vsac |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.1444.5.208.json | Carboplatin | active | | | 2020-09 | us | hl7 | vsac |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.1444.5.209.json | Depression Screening for Adult | active | | | 2022-03 | us | hl7 | vsac |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.1444.5.210.json | Long Acting Opioids | active | | | 2020-10 | us | hl7 | vsac |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.1444.5.211.json | High Fiber Supplement or Diet Education | active | | | 2022-03 | us | hl7 | vsac |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.1444.5.212.json | Dexamethasone | active | | | 2021-03 | us | hl7 | vsac |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.1444.5.213.json | Olanzapine | active | | | 2021-03 | us | hl7 | vsac |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.1444.5.214.json | Pancreatic Cancer | active | | | 2020-10 | us | hl7 | vsac |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.1444.5.215.json | Audio Visual Telehealth Encounter | active | | | 2025-02 | us | hl7 | vsac |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.1444.5.216.json | Telephone Encounter | active | | | 2022-03 | us | hl7 | vsac |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.1444.5.217.json | Telehealth Emergency Department or Initial Inpatient | active | | | 2024-07 | us | hl7 | vsac |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.1444.5.218.json | Dyspnea Assessment | active | | | 2022-03 | us | hl7 | vsac |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.1444.5.219.json | Nausea or Vomiting Assessment | active | | | 2022-03 | us | hl7 | vsac |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.1444.5.220.json | Karnofsky Performance Status | active | | | 2022-03 | us | hl7 | vsac |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.1444.5.221.json | Referral to Hospice Care | active | | | 2022-03 | us | hl7 | vsac |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.1444.5.222.json | Referral to Palliative Care | active | | | 2022-03 | us | hl7 | vsac |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.1444.5.223.json | Palliative Care | active | | | 2022-03 | us | hl7 | vsac |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.1444.5.224.json | Enrollment in Hospice Care | active | | | 2022-03 | us | hl7 | vsac |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.1444.5.225.json | Advance Directive Including Durable Power of Attorney or Instructional | active | | | 2022-03 | us | hl7 | vsac |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.1444.5.229.json | Minimal Emetic Risk Intravenous Antineoplastic Agent | active | | | 2025-04 | us | hl7 | vsac |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.1444.5.232.json | Epithelial Ovarian Cancer | active | | | 2023-06 | us | hl7 | vsac |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.1444.5.233.json | Primary Peritoneal Cancer | active | | | 2022-06 | us | hl7 | vsac |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.1444.5.235.json | BRCA2 Testing | active | | | 2023-06 | us | hl7 | vsac |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.1444.5.236.json | Multigene Panel | active | | | 2023-07 | us | hl7 | vsac |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.1444.5.237.json | BRCA1 Testing | active | | | 2023-06 | us | hl7 | vsac |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.1444.5.238.json | First Line Drug Therapy for Metastatic Colorectal Cancer | active | | | 2022-01 | us | hl7 | vsac |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.1444.5.239.json | BRAF V600 Testing | active | | | 2022-01 | us | hl7 | vsac |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.1444.5.240.json | Cancer Stage 4 | active | | | 2022-01 | us | hl7 | vsac |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.1444.5.241.json | Cancer Stage M1 | active | | | 2024-12 | us | hl7 | vsac |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.1444.5.242.json | High Emetic Risk Intravenous Antineoplastic Agent | active | | | 2022-09 | us | hl7 | vsac |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.1444.5.243.json | Moderate Emetic Risk Intravenous Antineoplastic Agent | active | | | 2024-10 | us | hl7 | vsac |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.1444.5.245.json | Antiemetic Agent | active | | | 2025-04 | us | hl7 | vsac |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.1444.5.247.json | Indication for Dexamethasone | active | | | 2025-04 | us | hl7 | vsac |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.1444.5.249.json | Indication for Olanzapine | active | | | 2025-04 | us | hl7 | vsac |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.2074.1.1.3.json | Race Category Excluding Nulls | active | | | 2024-06 | us | hl7 | oid |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.3157.1002.77.json | Codeine | active | | | 2024-02 | us | hl7 | rx |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.3157.1004.13.json | Dihydrocodeine | active | | | 2024-02 | us | hl7 | rx |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.3157.1004.14.json | Nalbuphine | active | | | 2020-03 | us | hl7 | rx |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.3157.4009.json | Malignant Intracranial Neoplasm | active | | | 2024-02 | us | hl7 | sct |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.3157.4010.json | Malignant Intracranial Neoplasm | active | | | 2023-02 | us | hl7 | icd |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.3157.4015.json | STEMI | active | | | 2022-02 | us | hl7 | icd |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.3157.4016.json | STEMI | active | | | 2019-02 | us | hl7 | sct |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.3157.4017.json | STEMI | active | | | 2022-03 | us | hl7 | vsac |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.3157.4019.json | Fibrinolytic Therapy | active | | | 2023-02 | us | hl7 | rx |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.3157.4023.json | Cerebral Vascular Lesion | active | | | 2025-02 | us | hl7 | icd |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.3157.4024.json | Cerebral Vascular Lesion | active | | | 2025-02 | us | hl7 | sct |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.3157.4025.json | Cerebral Vascular Lesion | active | | | 2019-02 | us | hl7 | vsac |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.3157.4026.json | Closed Head and Facial Trauma | active | | | 2019-02 | us | hl7 | vsac |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.3157.4028.json | Aortic Dissection or Ruptured Aortic Aneurysm | active | | | 2022-03 | us | hl7 | vsac |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.3157.4029.json | Acute Peptic Ulcer | active | | | 2023-02 | us | hl7 | icd |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.3157.4030.json | Acute Peptic Ulcer | active | | | 2023-02 | us | hl7 | sct |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.3157.4031.json | Acute Peptic Ulcer | active | | | 2022-03 | us | hl7 | vsac |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.3157.4032.json | Dementia and Related Intracranial Pathologies | active | | | 2025-02 | us | hl7 | icd |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.3157.4033.json | Dementia and Related Intracranial Pathologies | active | | | 2025-02 | us | hl7 | sct |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.3157.4034.json | Active Bleeding or Bleeding Diathesis, Excluding Menses | active | | | 2025-02 | us | hl7 | icd |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.3157.4035.json | Active Bleeding or Bleeding Diathesis, Excluding Menses | active | | | 2022-02 | us | hl7 | sct |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.3157.4036.json | Active Bleeding or Bleeding Diathesis, Excluding Menses | active | | | 2022-03 | us | hl7 | vsac |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.3157.4043.json | Dementia and Related Intracranial Pathologies | active | | | 2022-03 | us | hl7 | vsac |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.3157.4044.json | Aortic Dissection or Ruptured Aortic Aneurysm | active | | | 2022-02 | us | hl7 | sct |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.3157.4045.json | Oral Anticoagulant Medications | active | | | 2023-02 | us | hl7 | rx |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.3157.4046.json | Cardiopulmonary Emergency | active | | | 2025-02 | us | hl7 | icd |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.3157.4047.json | Cardiopulmonary Emergency | active | | | 2025-02 | us | hl7 | sct |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.3157.4048.json | Cardiopulmonary Emergency | active | | | 2022-03 | us | hl7 | vsac |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.3157.4049.json | Mechanical Circulatory Assist Device | active | | | 2024-07 | us | hl7 | sct |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.3157.4050.json | Mechanical Circulatory Assist Device | active | | | 2025-02 | us | hl7 | cpt |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.3157.4052.json | Mechanical Circulatory Assist Device | active | | | 2025-02 | us | hl7 | vsac |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.3157.4053.json | Pregnant State | active | | | 2022-02 | us | hl7 | icd |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.3157.4054.json | Pregnant State | active | | | 2024-07 | us | hl7 | sct |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.3157.4055.json | Pregnant State | active | | | 2022-03 | us | hl7 | vsac |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.3157.4056.json | Major Surgical Procedure | active | | | 2022-03 | us | hl7 | vsac |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.3566.2.1005.json | Chronic Stable Angina | active | | | 2024-02 | us | hl7 | icd |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.3566.2.1006.json | Chronic Stable Angina | active | | | 2023-02 | us | hl7 | sct |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.3566.3.1002.json | Chronic Stable Angina | active | | | 2021-04 | us | hl7 | vsac |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.464.1003.1001.json | Hospice Encounter | active | | | 2021-08 | us | hl7 | cms |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.464.1003.1002.json | Hospice Encounter | active | | | 2023-02 | us | hl7 | sct |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.464.1003.1003.json | Hospice Encounter | active | | | 2022-03 | us | hl7 | vsac |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.464.1003.1004.json | Nutrition Services | active | | | 2021-09 | us | hl7 | sct |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.464.1003.1005.json | Nutrition Services | active | | | 2021-08 | us | hl7 | cms |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.464.1003.1006.json | Nutrition Services | active | | | 2022-03 | us | hl7 | vsac |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.464.1003.1007.json | Hospice Care Ambulatory | active | | | 2021-08 | us | hl7 | cpt |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.464.1003.1008.json | Hospice Care Ambulatory | active | | | 2021-08 | us | hl7 | cms |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.464.1003.101.11.1005.json | Office Visit | active | | | 2023-11 | us | hl7 | cpt |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.464.1003.101.11.1020.json | Initial Hospital Inpatient Visit | active | | | 2017-05 | us | hl7 | cpt |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.464.1003.101.11.1030.json | Discharge Services Hospital Inpatient Same Day Discharge | active | | | 2017-05 | us | hl7 | cpt |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.464.1003.101.11.1035.json | Discharge Services Hospital Inpatient | active | | | 2017-05 | us | hl7 | cpt |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.464.1003.101.11.1040.json | Outpatient Consultation | active | | | 2024-02 | us | hl7 | cpt |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.464.1003.101.11.1050.json | Emergency Department Evaluation and Management Visit | active | | | 2017-05 | us | hl7 | cpt |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.464.1003.101.11.1060.json | Nursing Facility Visit | active | | | 2024-02 | us | hl7 | cpt |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.464.1003.101.11.1065.json | Discharge Services Nursing Facility | active | | | 2017-05 | us | hl7 | cpt |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.464.1003.101.11.1080.json | Home Healthcare Services | active | | | 2024-02 | us | hl7 | cpt |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.464.1003.101.11.1110.json | Preventive Care, Initial Office Visit, 0 to 17 | active | | | 2017-05 | us | hl7 | cpt |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.464.1003.101.11.1115.json | Preventive Care Services Initial Office Visit, 18 and Up | active | | | 2017-05 | us | hl7 | cpt |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.464.1003.101.11.1120.json | Preventive Care, Established Office Visit, 0 to 17 | active | | | 2017-05 | us | hl7 | cpt |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.464.1003.101.11.1125.json | Preventive Care Services Established Office Visit, 18 and Up | active | | | 2017-05 | us | hl7 | cpt |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.464.1003.101.11.1130.json | Preventive Care Services Individual Counseling | active | | | 2017-05 | us | hl7 | cpt |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.464.1003.101.11.1135.json | Preventive Care Services Group Counseling | active | | | 2017-05 | us | hl7 | cpt |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.464.1003.101.11.1215.json | Referral | active | | | 2023-02 | us | hl7 | sct |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.464.1003.101.11.1216.json | Face-to-Face Interaction | active | | | 2017-05 | us | hl7 | sct |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.464.1003.101.11.1221.json | Behavioral Health Follow up Visit | active | | | 2020-03 | us | hl7 | cpt |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.464.1003.101.11.1222.json | Psychotherapy and Pharmacologic Management | active | | | 2017-05 | us | hl7 | cpt |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.464.1003.101.11.1228.json | Detoxification Visit | active | | | 2021-02 | us | hl7 | sct |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.464.1003.101.11.1232.json | Audiology Visit | active | | | 2017-05 | us | hl7 | cpt |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.464.1003.101.11.1233.json | Medical Disability Exam | active | | | 2019-03 | us | hl7 | cpt |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.464.1003.101.11.1260.json | Telephone Visits | active | | | 2025-02 | us | hl7 | cpt |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.464.1003.101.11.1261.json | Nursing Facility Visit | active | | | 2018-03 | us | hl7 | sct |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.464.1003.101.11.1262.json | Care Services in Long Term Residential Facility | active | | | 2018-03 | us | hl7 | sct |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.464.1003.101.11.1264.json | Office Visit | active | | | 2025-01 | us | hl7 | sct |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.464.1003.101.11.1265.json | Home Healthcare Services | active | | | 2021-02 | us | hl7 | sct |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.464.1003.101.11.1266.json | Outpatient Consultation | active | | | 2020-03 | us | hl7 | sct |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.464.1003.101.11.1276.json | Frailty Encounter | active | | | 2019-03 | us | hl7 | cpt |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.464.1003.101.11.1277.json | Outpatient Encounter | active | | | 2025-03 | us | hl7 | cpt |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.464.1003.101.11.1278.json | Outpatient Encounter | active | | | 2025-03 | us | hl7 | cms |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.464.1003.101.11.1279.json | Frailty Encounter | active | | | 2019-03 | us | hl7 | cms |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.464.1003.101.11.1284.json | Outpatient Encounter | active | | | 2023-11 | us | hl7 | sct |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.464.1003.101.11.1285.json | Palliative Encounter | active | | | 2025-01 | us | hl7 | cms |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.464.1003.101.11.1286.json | Palliative Encounter | active | | | 2024-02 | us | hl7 | sct |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.464.1003.101.11.1287.json | Telephone Visits | active | | | 2021-02 | us | hl7 | sct |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.464.1003.101.12.1001.json | Office Visit | active | | | 2022-03 | us | hl7 | vsac |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.464.1003.101.12.1004.json | Initial Hospital Inpatient Visit | active | | | 2017-05 | us | hl7 | vsac |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.464.1003.101.12.1006.json | Discharge Services Hospital Inpatient Same Day Discharge | active | | | 2017-05 | us | hl7 | vsac |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.464.1003.101.12.1007.json | Discharge Services Hospital Inpatient | active | | | 2017-05 | us | hl7 | vsac |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.464.1003.101.12.1008.json | Outpatient Consultation | active | | | 2024-01 | us | hl7 | vsac |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.464.1003.101.12.1010.json | Emergency Department Evaluation and Management Visit | active | | | 2022-03 | us | hl7 | vsac |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.464.1003.101.12.1012.json | Nursing Facility Visit | active | | | 2024-01 | us | hl7 | vsac |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.464.1003.101.12.1013.json | Discharge Services Nursing Facility | active | | | 2017-05 | us | hl7 | vsac |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.464.1003.101.12.1014.json | Care Services in Long Term Residential Facility | active | | | 2024-02 | us | hl7 | vsac |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.464.1003.101.12.1016.json | Home Healthcare Services | active | | | 2024-01 | us | hl7 | vsac |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.464.1003.101.12.1022.json | Preventive Care Services, Initial Office Visit, 0 to 17 | active | | | 2017-05 | us | hl7 | vsac |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.464.1003.101.12.1023.json | Preventive Care Services Initial Office Visit, 18 and Up | active | | | 2017-05 | us | hl7 | vsac |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.464.1003.101.12.1024.json | Preventive Care, Established Office Visit, 0 to 17 | active | | | 2017-05 | us | hl7 | vsac |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.464.1003.101.12.1025.json | Preventive Care Services Established Office Visit, 18 and Up | active | | | 2017-05 | us | hl7 | vsac |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.464.1003.101.12.1026.json | Preventive Care Services Individual Counseling | active | | | 2017-05 | us | hl7 | vsac |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.464.1003.101.12.1027.json | Preventive Care Services Group Counseling | active | | | 2017-05 | us | hl7 | vsac |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.464.1003.101.12.1046.json | Referral | active | | | 2022-03 | us | hl7 | vsac |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.464.1003.101.12.1048.json | Face-to-Face Interaction | active | | | 2022-03 | us | hl7 | vsac |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.464.1003.101.12.1054.json | Behavioral Health Follow up Visit | active | | | 2017-05 | us | hl7 | vsac |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.464.1003.101.12.1055.json | Psychotherapy and Pharmacologic Management | active | | | 2017-05 | us | hl7 | vsac |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.464.1003.101.12.1059.json | Detoxification Visit | active | | | 2022-03 | us | hl7 | vsac |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.464.1003.101.12.1066.json | Audiology Visit | active | | | 2017-05 | us | hl7 | vsac |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.464.1003.101.12.1073.json | Medical Disability Exam | active | | | 2021-03 | us | hl7 | vsac |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.464.1003.101.12.1080.json | Telephone Visits | active | | | 2025-02 | us | hl7 | vsac |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.464.1003.101.12.1087.json | Outpatient Encounter | active | | | 2025-03 | us | hl7 | vsac |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.464.1003.101.12.1088.json | Frailty Encounter | active | | | 2021-02 | us | hl7 | vsac |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.464.1003.101.12.1090.json | Palliative Care Encounter | active | | | 2022-03 | us | hl7 | vsac |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.464.1003.1010.json | Multiple Myeloma | active | | | 2021-08 | us | hl7 | icd |